With Indivior’s stock price in freefall over the past year, one of the company’s top investors is taking leadership to task, ...

Updates shares, adds investor letter, company response.  Indivior PLC (NASDAQ:INDV) soared 13% amid some takeover speculation ...

Indivior (GB:INDV) has released an update. Deerfield Management Company has acquired a significant 5.165% stake in Indivior PLC, marking a ...

Indivior Plc has entered into a refinancing agreement that would allow it to push back the maturity on its existing term loan ...

Investment fund Oaktree Capital Management has urged British drugmaker Indivior to cooperate with the fund in refreshing its ...

Investment fund Oaktree Capital Management has written to Indivior urging the opioid addiction treatment maker to refresh its ...

Indivior (GB:INDV) has released an update. Indivior PLC is actively engaging with Oaktree Capital Management to explore proposals aimed at ...

M&G Plc lowered its stake in shares of Indivior PLC (NASDAQ:INDV – Free Report) by 6.4% during the third quarter, according to the company in its most recent disclosure with the Securities and ...

Indivior has failed in its bid to prevent a lawsuit claiming that it illegally blocked competition to opioid addiction drug Suboxone from coming to court in the US.

Indivior PLC (NASDAQ:INDV) is set to release its Q3 2024 earnings on Oct 24, 2024. The consensus estimate for Q3 2024 revenue ...

Piper Sandler raised the firm’s price target on Indivior (INDV) to $16 from $15 and keeps an Overweight rating on the shares after Q3 earnings. Though the optics of multiple downward revisions ...

Oaktree Capital Management, L.p. Nov 7 (Reuters) - Investment fund Oaktree Capital Management has urged British drugmaker Indivior (INDV.L), opens new tab to cooperate with the fund in refreshing ...